Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

EC wants pharma feedback on clinical trial inspector expectations

Clinical trial inspectors will need a University degree and familiarity with modern data management principles under European Commission proposals.

Boehringer-Ingelheim licenses microbial expression tech for in-house and out

Boehringer Ingelheim has licensed a microbial expression technology from Vectron Biosolutions for use with its own molecules and for customers through its CMO business.

Bear-faced lie? Amgen retracts diabetes-obesity paper due to data manipulation

Amgen has retracted a study showing how grizzly bears could hold the key to understanding diabetes after one of the authors was found to have manipulated data.

Japan industry group to examine clinical site cost discrepancies

Japanese industry group JPMA has opted for cloud-based tech to help it understand why the cost of running a trial in the country varies depending on the site involved.

AMRI boosts opiate API biz through tech transfer and supply deal with Saneca

AMRI has inked a deal with Slovakia’s Saneca Pharmaceuticals to bolster its opium-derived API portfolio.

Europe bans drugs tested by GVK; FDA monitors but keeps allowing sales

The US FDA has found no systemic issues affecting the safety or efficacy of generics clinically tested at GVK BioSciences, but says it supports Europe’s ban of around 700 products.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...